These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21031377)

  • 1. Oxetanes as versatile elements in drug discovery and synthesis.
    Burkhard JA; Wuitschik G; Rogers-Evans M; Müller K; Carreira EM
    Angew Chem Int Ed Engl; 2010 Nov; 49(48):9052-67. PubMed ID: 21031377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxetanes in drug discovery: structural and synthetic insights.
    Wuitschik G; Carreira EM; Wagner B; Fischer H; Parrilla I; Schuler F; Rogers-Evans M; Müller K
    J Med Chem; 2010 Apr; 53(8):3227-46. PubMed ID: 20349959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and stability of oxetane analogs of thalidomide and lenalidomide.
    Burkhard JA; Wuitschik G; Plancher JM; Rogers-Evans M; Carreira EM
    Org Lett; 2013 Sep; 15(17):4312-5. PubMed ID: 23937240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxetanes in Drug Discovery Campaigns.
    Rojas JJ; Bull JA
    J Med Chem; 2023 Sep; 66(18):12697-12709. PubMed ID: 37676858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(Aryl-sulfonyl)oxetanes as designer 3-dimensional fragments for fragment screening: synthesis and strategies for functionalisation.
    Morgan KF; Hollingsworth IA; Bull JA
    Chem Commun (Camb); 2014 May; 50(40):5203-5. PubMed ID: 24175317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxetanes as promising modules in drug discovery.
    Wuitschik G; Rogers-Evans M; Müller K; Fischer H; Wagner B; Schuler F; Polonchuk L; Carreira EM
    Angew Chem Int Ed Engl; 2006 Nov; 45(46):7736-9. PubMed ID: 17013952
    [No Abstract]   [Full Text] [Related]  

  • 7. C-H Insertion as a Key Step to Spiro-Oxetanes, Scaffolds for Drug Discovery.
    Nicolle SM; Nortcliffe A; Bartrum HE; Lewis W; Hayes CJ; Moody CJ
    Chemistry; 2017 Oct; 23(55):13623-13627. PubMed ID: 28796404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of diversely functionalised 2,2-disubstituted oxetanes: fragment motifs in new chemical space.
    Davis OA; Croft RA; Bull JA
    Chem Commun (Camb); 2015 Oct; 51(84):15446-9. PubMed ID: 26344367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the synthesis, stability and conformation of 2-sulfonyl-oxetane fragments.
    Morgan KF; Hollingsworth IA; Bull JA
    Org Biomol Chem; 2015 May; 13(18):5265-72. PubMed ID: 25857425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of oxetanes in drug discovery and medicinal chemistry.
    Huang G; Hucek D; Cierpicki T; Grembecka J
    Eur J Med Chem; 2023 Dec; 261():115802. PubMed ID: 37713805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrochemical approach to the repair of oxetanes mimicking DNA (6-4) photoproducts.
    Boussicault F; Robert M
    J Phys Chem B; 2006 Nov; 110(43):21987-93. PubMed ID: 17064168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adventures in drug-like chemistry space: from oxetanes to spiroazetidines and beyond!
    Rogers-Evans M; Knust H; Plancher JM; Carreira EM; Wuitschik G; Burkhard J; Li DB; Guérot C
    Chimia (Aarau); 2014; 68(7-8):492-9. PubMed ID: 25437389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry.
    Bull JA; Croft RA; Davis OA; Doran R; Morgan KF
    Chem Rev; 2016 Oct; 116(19):12150-12233. PubMed ID: 27631342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hip To Be Square: Oxetanes as Design Elements To Alter Metabolic Pathways.
    Toselli F; Fredenwall M; Svensson P; Li XQ; Johansson A; Weidolf L; Hayes MA
    J Med Chem; 2019 Aug; 62(16):7383-7399. PubMed ID: 31310524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-Selective Modification of Proteins with Oxetanes.
    Boutureira O; Martínez-Sáez N; Brindle KM; Neves AA; Corzana F; Bernardes GJL
    Chemistry; 2017 May; 23(27):6483-6489. PubMed ID: 28261889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model compounds for (6-4) photolyases: a comparative flavin induced cleavage study of oxetanes and thietanes.
    Friedel MG; Cichon MK; Carell T
    Org Biomol Chem; 2005 May; 3(10):1937-41. PubMed ID: 15889177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Densely functionalised spirocyclic oxetane-piperidine scaffolds for drug discovery.
    Geary GC; Nortcliffe A; Pearce CA; Hamza D; Jones G; Moody CJ
    Bioorg Med Chem; 2018 Feb; 26(4):791-797. PubMed ID: 29366687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving molecules using multi-objective optimization: applying to ADME/Tox.
    Ekins S; Honeycutt JD; Metz JT
    Drug Discov Today; 2010 Jun; 15(11-12):451-60. PubMed ID: 20438859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.